Cellectis S.A. (CLLS) vs VAXART, INC. (VXRT)
- Cellectis S.A. CLLS 1.26 +0.80%
- VAXART, INC. VXRT 0.43 0.00%
Cellectis S.A. and VAXART, INC. are both Biotechnology companies. Cellectis S.A. and VAXART, INC. are of similar size ($92.4M and $90.4M). Cellectis S.A. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 201.1% against 0.61%. VAXART, INC. has the higher net margin (15.9% vs −102.3%) and the higher return on invested capital (134.6% vs 0.00%). Across the 17 metrics below, VAXART, INC. leads on 17 and Cellectis S.A. on 0.
Valuation
Profitability
| Metric | CLLS | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (90.88%) | 16.30% | 0.00% |
| Net margin | (102.34%) | 15.88% | 0.00% |
| Free cash flow margin | (68.63%) | 13.74% | 0.00% |
| Return on equity | (94.54%) | 66.97% | (56.66%) |
| Return on assets | (21.02%) | 23.44% | (49.22%) |
| Return on invested capital | 0.00% | 134.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack